Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlighted strong financial performance with increased revenue and EPS, a dividend hike, and substantial capital investments. The Q&A session revealed optimism about regulatory timelines and proactive strategies for addressing PFAS issues. Despite some uncertainties in PFAS cost settlements, the overall sentiment remains positive due to robust financial metrics, strategic investments, and shareholder returns. Given the company's market cap, the stock price is likely to react positively in the short term.
Non-GAAP EPS (Earnings Per Share) Non-GAAP earnings per share were up 15% year-over-year. This increase is historically significant, especially considering it is the third year of the rate case in California, which is the company's largest operating entity.
Revenue (Q2 2025) Revenue increased $20.7 million or 8.5% to $265 million compared to $244.3 million in Q2 2024. Compared to non-GAAP 2024 revenue, second quarter revenue increased $17.9 million or 7.2%. The increase was driven by tariff rate changes and increased customer usage.
Net Income (Q2 2025) Net income for the quarter was $42.2 million or $0.71 per diluted share, compared to $40.6 million or $0.70 per diluted share in Q2 2024. Compared to non-GAAP 2024 net income, Q2 net income decreased $200,000 or $0.02 per diluted share. The decrease was due to the finalization of amounts recorded in 2024 related to the 2023 interim rates.
Year-to-Date Revenue (2025) Revenue through the first 6 months of 2025 was $468.9 million compared to $515 million for the same period in 2024. Adjusting for interim rate relief, year-to-date 2025 revenue increased $41.3 million or 9.7%. The increase was driven by tariff rate changes and increased customer usage.
Year-to-Date Net Income (2025) Net income attributed to the group was $55.5 million or $0.93 per diluted share compared to $110.5 million or $1.90 per diluted share in 2024. Adjusting for interim rate relief, net income increased $9 million or 19.4% over non-GAAP 2024 year-to-date net income, while diluted earnings per share increased $0.12 or 14.8%.
Capital Investments (Q2 2025) Capital investments for the quarter were $119.4 million, representing a 14.2% increase compared to the same period in 2024. This increase reflects the company's commitment to infrastructure improvements.
Capital Investments (Year-to-Date 2025) Year-to-date capital investments were $229.5 million, a 7% increase compared to the same period in 2024. This increase is part of the company's ongoing efforts to ensure the delivery of safe and reliable water service.
New contract in California and Silverwood: Entered into an agreement to build, own, operate, and finance a wastewater treatment facility for a new development in Southern California. The facility will serve over 15,000 customer connections and deliver more than 3 million gallons per day of tertiary treated wastewater, with 100% reuse within the community.
Texas market expansion: Continued growth in the Austin-San Antonio region, with increasing customer connections and commitments. Filed a general rate case for five utilities in Texas, reaching an all-party settlement awaiting commission approval.
Capital investments: Invested $119.4 million in Q2 and $229.5 million year-to-date in water infrastructure, representing a 14.2% and 7% increase respectively compared to 2024. Plans for $1.6 billion in infrastructure improvements in California over the next three years.
PFAS-related investments: Committed to $226 million in PFAS treatment projects, with $10.6 million already received from a settlement with 3M. Adjusting plans based on evolving EPA guidelines and state regulations.
Sustainability initiatives: Published a 2024 sustainability report highlighting goals to reduce greenhouse gas emissions by 23.5%, $3 million in energy-efficient upgrades, and 100% compliance with water quality standards. Expanded employee training programs and supplier diversity efforts.
Dividend growth: Announced a 10.71% increase in quarterly dividends, reflecting a 5-year compound annual growth rate of 7.7%.
Regulatory Delays: The 2021 general rate case was delayed by 16 months, causing retroactive adjustments that have created financial reporting challenges and earnings volatility.
PFAS Compliance Costs: The company faces significant costs related to PFAS treatment and compliance, with an estimated $220 million in expenditures over the next few years. Regulatory uncertainty and state-specific rules add complexity.
Rate Case Uncertainty: The California General Rate Case for 2026-2028 is critical, with $398 million requested. No settlement was reached with the ratepayer advocate, leading to prolonged proceedings and potential delays in approval.
Climate Change Adaptation: The company is investing heavily in infrastructure improvements to address climate change, but this requires significant capital and carries execution risks.
Texas Infrastructure Challenges: Rapid growth in the Austin-San Antonio region presents opportunities but also challenges in timely infrastructure development, particularly for water systems.
Litigation and Recovery Risks: The company is involved in litigation to recover costs from PFAS contamination. While initial settlements have been reached, the process is ongoing and uncertain.
Economic and Market Conditions: The company’s growth and capital investment plans are sensitive to broader economic conditions, including interest rates and credit availability.
Capital Investments: The company plans to invest $1.6 billion in infrastructure improvements in California over the years 2026, 2027, and 2028 as part of its climate change adaptation plans. Additionally, $220 million is allocated for PFAS project expenditures over the next few years.
Rate Base Growth: If approved, the 2024 General Rate Case and infrastructure improvement plan, along with planned capital investments, would result in a compounded annual rate base growth of almost 12%.
PFAS Compliance: The company is committed to investing $226 million in PFAS-related projects, with plans to align with evolving EPA guidelines and state regulations. Investments will begin to show in the second half of 2025 and continue into 2026 and 2027.
Texas Expansion: The Texas subsidiary is growing in line with the rapid expansion of the Austin-San Antonio region, projected to grow from 5 million to 8 million people by 2050. The company is aligning utility investments to support this growth.
New Developments: The company has entered into an agreement to build, own, operate, and finance a wastewater treatment facility for a new master-planned community in Southern California, which will consist of over 15,000 customer connections and deliver over 3 million gallons per day of tertiary treated wastewater.
Dividend Growth: The company announced a 10.71% increase in its quarterly dividend earlier this year, reflecting a 5-year compound annual growth rate of 7.7%.
Quarterly Dividend: The Board of Directors approved the 322nd quarterly dividend in the amount of $0.30 per share.
Dividend Increase: Earlier this year, the Board approved a 10.71% increase in the dividend, resulting in a 5-year compound annual growth rate of 7.7% for the dividend.
The earnings call summary reflects a generally positive outlook. The basic financial performance is strong with a 12% rate base growth, and the Texas expansion aligns with demographic trends. The shareholder return plan is positive with a 10.71% dividend increase. Despite some uncertainties in project details, the Q&A section reveals strong customer interest and stable utility returns. The market cap of approximately $2.8 billion suggests a moderate response, resulting in a positive stock price prediction of 2% to 8%.
The earnings call reveals mixed signals: stable financial performance with a slight revenue increase, but significant net income decline YoY. Positive factors include a strong dividend growth rate and strategic capital investments. However, the Q&A highlighted management's evasiveness on rate base growth concerns, which could unsettle investors. The market cap suggests moderate reactions. Overall, the combination of stable earnings, strong dividends, and management's unclear responses leads to a neutral sentiment.
The earnings call highlighted strong financial performance with increased revenue and EPS, a dividend hike, and substantial capital investments. The Q&A session revealed optimism about regulatory timelines and proactive strategies for addressing PFAS issues. Despite some uncertainties in PFAS cost settlements, the overall sentiment remains positive due to robust financial metrics, strategic investments, and shareholder returns. Given the company's market cap, the stock price is likely to react positively in the short term.
Basic Financial Performance: 3 (Neutral) - Despite adjusted revenue and net income growth, overall revenue and net income decreased. Product Development and Business Update: 3 (Neutral) - Growth in Texas and infrastructure plans are positive, but regulatory risks remain. Market Strategy: 3 (Neutral) - No new partnerships or major strategic shifts announced. Expenses and Financial Health: 3 (Neutral) - Strong liquidity but supply chain and economic risks persist. Shareholder Return Plan: 4 (Positive) - Dividend increase is positive. Overall, mixed results and regulatory risks lead to a neutral outlook.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.